Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the effectiveness and safety of prolonged-release OROS methylphenidate in adults with ADHD has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Attention Deficit/ Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-04-21